Spontaneous rectus sheath hematoma during rivaroxaban therapy

Ibrahim Kocayigit; Yusuf Can; Salih Sahinkus; Ercan Aydin; Mehmet Bulent Vatan; Harun Kilic; Huseyin Gunduz

doi:10.4103/0253-7613.132193

	Home	IPS	Feedback	Subscribe	Top cited articles	Login

Users Online : 2150

Announcement

» Next article

» Previous article

» Table of Contents

» Similar in PUBMED

» Search Pubmed for

» Search in Google Scholar for

»Related articles

» Citation Manager

» Access Statistics

» Reader Comments

» Email Alert *

» Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	3219

Printed	147

Emailed	0

PDF Downloaded	90

Comments	[Add]

Cited by others	5

Click on image for details.

DRUG WATCH

Year : 2014 | Volume : 46 | Issue : 3 | Page : 339-340

Spontaneous rectus sheath hematoma during rivaroxaban therapy

Ibrahim Kocayigit¹, Yusuf Can², Salih Sahinkus², Ercan Aydin³, Mehmet Bulent Vatan², Harun Kilic², Huseyin Gunduz²
¹ Department of Cardiology, Yenikent State Hospital, Turkey
² Department of Cardiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey
³ Department of Cardiology, Vakfikebir State Hospital, Trabzon, Turkey

Correspondence Address:
Ibrahim Kocayigit
Department of Cardiology, Yenikent State Hospital
Turkey

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/0253-7613.132193

Rivaroxaban is an oral anticoagulant agent that directly inhibits Factor Xa and interrupts both the intrinsic and extrinsic pathway of the coagulation cascade and is currently indicated for use in patients for atrial fibrillation and prophylaxis of deep venous thrombosis. The present case reports of spontaneous rectus sheath hematoma during rivaroxaban therapy for atrial fibrillation in a 75-year-old woman.

[FULL TEXT] [PDF]*

Online since 20^th July '04

Published by Wolters Kluwer - Medknow